BRM
ABT icon

Boston Research & Management’s Abbott ABT Stock Holding History

Boston Research & Management’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.13M Buy
59,676
+2,955
+5% +$334K 1.46% 29
2025
Q4 		$7.11M Sell
56,721
-2,616
-4% -$333K 1.64% 19
2025
Q3 		$7.95M Buy
59,337
+942
+2% +$124K 1.75% 16
2025
Q2 		$7.94M Sell
58,395
-921
-2% -$121K 1.9% 15
2025
Q1 		$7.87M Sell
59,316
-3,050
-5% -$388K 1.95% 13
2024
Q4 		$7.05M Sell
62,366
-24
-0% -$2.77K 1.73% 18
2024
Q3 		$7.11M Buy
62,390
+465
+0.8% +$51K 1.67% 20
2024
Q2 		$6.43M Buy
61,925
+141
+0.2% +$14.9K 1.63% 20
2024
Q1 		$7.02M Buy
61,784
+61
+0.1% +$6.99K 1.74% 19
2023
Q4 		$6.79M Buy
61,723
+1,340
+2% +$134K 1.8% 16
2023
Q3 		$5.85M Buy
60,383
+490
+0.8% +$51.5K 1.73% 18
2023
Q2 		$6.53M Buy
59,893
+299
+0.5% +$31.9K 1.85% 16
2023
Q1 		$6.03M Buy
59,594
+590
+1% +$62.3K 1.8% 19
2022
Q4 		$6.48M Sell
59,004
-2,140
-3% -$222K 2% 14
2022
Q3 		$5.92M Buy
61,144
+2,415
+4% +$257K 2.02% 11
2022
Q2 		$6.38M Buy
58,729
+675
+1% +$76.7K 2.07% 10
2022
Q1 		$6.87M Sell
58,054
-1,197
-2% -$148K 1.99% 15
2021
Q4 		$8.34M Sell
59,251
-115
-0.2% -$14.7K 2.28% 8
2021
Q3 		$7.01M Buy
59,366
+420
+0.7% +$51.6K 2.09% 12
2021
Q2 		$6.83M Buy
58,946
+2,325
+4% +$271K 2.07% 12
2021
Q1 		$6.79M Sell
56,621
-1,050
-2% -$124K 2.18% 9
2020
Q4 		$6.31M Sell
57,671
-196
-0.3% -$21.3K 2.2% 10
2020
Q3 		$6.3M Sell
57,867
-2,348
-4% -$238K 2.46% 8
2020
Q2 		$5.5M Sell
60,215
-166
-0.3% -$15K 2.29% 12
2020
Q1 		$4.76M Sell
60,381
-356
-0.6% -$29.7K 2.39% 10
2019
Q4 		$5.28M Sell
60,737
-250
-0.4% -$20.9K 1.98% 13
2019
Q3 		$5.1M Sell
60,987
-915
-1% -$77.7K 2.02% 15
2019
Q2 		$5.21M Sell
61,902
-740
-1% -$58.3K 2.11% 11
2019
Q1 		$5.01M Sell
62,642
-3,010
-5% -$224K 2.09% 10
2018
Q4 		$4.75M Buy
65,652
+7,550
+13% +$531K 2.26% 6
2018
Q3 		$4.26M Buy
58,102
+150
+0.3% +$9.85K 1.95% 17
2018
Q2 		$3.53M Sell
57,952
-1,140
-2% -$69.1K 1.74% 24
2018
Q1 		$3.54M Buy
59,092
+590
+1% +$35.5K 1.8% 22
2017
Q4 		$3.34M Sell
58,502
-2,705
-4% -$150K 1.67% 26
2017
Q3 		$3.27M Buy
61,207
+295
+0.5% +$14.8K 1.67% 28
2017
Q2 		$2.96M Buy
60,912
+100
+0.2% +$4.53K 1.6% 33
2017
Q1 		$2.7M Buy
60,812
+4,140
+7% +$179K 1.47% 39
2016
Q4 		$2.18M Sell
56,672
-6,055
-10% -$240K 1.24% 43
2016
Q3 		$2.65M Buy
62,727
+3,965
+7% +$170K 1.53% 32
2016
Q2 		$2.31M Buy
58,762
+4,638
+9% +$185K 1.4% 36
2016
Q1 		$2.26M Buy
54,124
+8,810
+19% +$349K 1.41% 34
2015
Q4 		$2.04M Buy
45,314
+2,450
+6% +$108K 1.27% 39
2015
Q3 		$1.72M Buy
42,864
+7,010
+20% +$330K 1.13% 41
2015
Q2 		$1.76M Buy
35,854
+250
+0.7% +$12K 1.11% 45
2015
Q1 		$1.65M Buy
35,604
+3,710
+12% +$170K 1.05% 44
2014
Q4 		$1.44M Buy
31,894
+280
+0.9% +$12.2K 0.9% 48
2014
Q3 		$1.31M Sell
31,614
-40
-0.1% -$1.69K 0.88% 51
2014
Q2 		$1.29M Buy
31,654
+1,262
+4% +$49.6K 0.89% 52
2014
Q1 		$1.17M Buy
30,392
+538
+2% +$20.7K 0.86% 50
2013
Q4 		$1.14M Buy
29,854
+3,542
+13% +$131K 0.88% 49
2013
Q3 		$873K Buy
26,312
+3,147
+14% +$110K 0.74% 53
2013
Q2 		$808K Buy
+23,165
New +$850K 0.72% 54

Other funds holding ABT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boston Research & Management's ABT Position: Q1 2026 in Review

Boston Research & Management increased its Abbott (ABT) stake by 5.2% in Q1 2026, buying an estimated $334K and bringing the position to 59,676 shares worth $6.13M. The position accounts for 1.46% of the portfolio, ranked #29.

Boston Research & Management first reported a position in ABT in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.34M in Q4 2021. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Boston Research & Management held 59,676 shares of Abbott worth $6.13M as of Q1 2026.
  • Boston Research & Management bought 2,955 Abbott shares in Q1 2026, an estimated $334K.
  • Abbott made up 1.46% of Boston Research & Management's portfolio in Q1 2026, its #29 holding.
  • Boston Research & Management first reported a position in Abbott in Q2 2013 and has held it in 52 quarters since.
  • Boston Research & Management's Abbott position peaked at $8.34M in Q4 2021.
  • 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Boston Research & Management's 13F filing for Q1 2026, filed 10 Apr 2026.